e-learning
resources
Stockholm 2007
Monday 17.09.2007
Biology of thoracic malignancies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clone and initial identification of differentially expressed genes of human small-cell lung cancer multi-drug resistance cell line
K. Li, G. Wu, F. Ji, G. Huang (Chongqing, China)
Source:
Annual Congress 2007 - Biology of thoracic malignancies
Session:
Biology of thoracic malignancies
Session type:
Electronic Poster Discussion
Number:
1811
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Li, G. Wu, F. Ji, G. Huang (Chongqing, China). Clone and initial identification of differentially expressed genes of human small-cell lung cancer multi-drug resistance cell line. Eur Respir J 2007; 30: Suppl. 51, 1811
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Relationship between mutated P53 and the acquired multi-drug resistance after cisplatin selection in NCI-H460 cell line of human large cell lung cancer
Source: Annual Congress 2004 - Molecular biology
Year: 2004
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
The effect of new drug-resistance antisense gene on multidrug resistance mechanism of drug-resistant human small cell lung cancer cells
Source: Eur Respir J 2007; 30: Suppl. 51, 715s
Year: 2007
Choice of endogenous control for gene expression in nonsmall cell lung cancer
Source: Eur Respir J 2005; 26: 1002-1008
Year: 2005
Identification of differentially expressed genes in squamous cell carcinoma of the lung using differential display
Source: Eur Respir J 2005; 26: Suppl. 49, 457s
Year: 2005
Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 400s
Year: 2002
Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient
Source: Eur Respir J , 49 (4) 1602149; DOI: 10.1183/13993003.02149-2016
Year: 2017
ABCG2 is determinant to SN-38 resistance in non-small cell lung cancer
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
Expression of RASGRF2 in non-small cell lung cancer and its effect of transfection on biological behavior of human NSCLC lines H1299
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
Lung adenocarcinoma subtypes based on expression of human airway basal cell genes
Source: Eur Respir J 2013; 42: 1332-1344
Year: 2013
HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
Relationship between a clinical drug resistance and immunohistochemical expression of P-glycoprotien, multidrug resistance protein, and p53 in small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 231s
Year: 2002
The selection of candidate microRNA biomarkers of acquired drug resistance in the lung adenocarcinoma cells treated with EGFR TKI
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Phenotype pattern of human non-small cell lung cancer (NSCLC) model line in immune escape phenomenon. Effect of transfection with plasmids encoding specific anti-EGFR1 and anti-HER2/neu short hairpin (SH)RNA sequences
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept